Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 535902, 7 pages
http://dx.doi.org/10.1155/2011/535902
Research Article

Early Detection of Tumor Response by FLT/MicroPET Imaging in a C26 Murine Colon Carcinoma Solid Tumor Animal Model

1Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan 32546, Taiwan
2Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei 11221, Taiwan

Received 21 April 2011; Revised 22 June 2011; Accepted 27 June 2011

Academic Editor: David J. Yang

Copyright © 2011 Wan-Chi Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Mankoff, J. F. Eary, J. M. Link et al., “Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond,” Clinical Cancer Research, vol. 13, no. 12, pp. 3460–3469, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. Leyton, J. R. Latigo, M. Perumal, H. Dhaliwal, Q. He, and E. O. Aboagye, “Early detection of tumor response to chemotherapy by 3′-deoxy- 3′-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo,” Cancer Research, vol. 65, no. 10, pp. 4202–4210, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. van Waarde, D. C. P. Cobben, A. J. H. Suurmeijer et al., “Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model,” Journal of Nuclear Medicine, vol. 45, no. 4, pp. 695–700, 2004. View at Google Scholar · View at Scopus
  4. C. Cohade, M. Osman, H. K. Pannu, and R. L. Wahl, “Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT,” Journal of Nuclear Medicine, vol. 44, no. 2, pp. 170–176, 2003. View at Google Scholar · View at Scopus
  5. A. Debucquoy, E. Devos, P. Vermaelen et al., “18F-FLT and FF-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models,” International Journal of Radiation Biology, vol. 85, no. 9, pp. 763–771, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. R. Bading and A. F. Shields, “Imaging of cell proliferation: status and prospects,” Journal of Nuclear Medicine, vol. 49, no. 6, supplement 2, pp. 64S–80S, 2008. View at Google Scholar
  7. J. S. Rasey, J. R. Grierson, L. W. Wiens, P. D. Kolb, and J. L. Schwartz, “Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells,” Journal of Nuclear Medicine, vol. 43, no. 9, pp. 1210–1217, 2002. View at Google Scholar · View at Scopus
  8. A. F. Shields, J. R. Grierson, B. M. Dohmen et al., “Imaging proliferation in vivo with [F-18]FLT and positron emission tomography,” Nature Medicine, vol. 4, no. 11, pp. 1334–1336, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. K. Imam, “Molecular nuclear imaging: the radiopharmaceuticals (review),” Cancer Biotherapy and Radiopharmaceuticals, vol. 20, no. 2, pp. 163–172, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. D. L. Francis, A. Freeman, D. Visvikis et al., “In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography,” Gut, vol. 52, no. 11, pp. 1602–1606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. L. van Westreenen, D. C. P. Cobben, P. L. Jager et al., “Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer,” Journal of Nuclear Medicine, vol. 46, no. 3, pp. 400–404, 2005. View at Google Scholar · View at Scopus
  12. A. K. Buck, G. Halter, H. Schirrmeister et al., “Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG,” Journal of Nuclear Medicine, vol. 44, no. 9, pp. 1426–1431, 2003. View at Google Scholar · View at Scopus
  13. H. Dittmann, B. M. Dohmen, F. Paulsen et al., “[18F]FLT PET for diagnosis and staging of thoracic tumours,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 10, pp. 1407–1412, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. W. G. E. Direcks, S. C. Berndsen, N. Proost et al., “[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study,” British Journal of Cancer, vol. 99, no. 3, pp. 481–487, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. N. Oyama, D. E. Ponde, C. Dence, J. Kim, Y. C. Tai, and M. J. Welch, “Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation,” Journal of Nuclear Medicine, vol. 45, no. 3, pp. 519–525, 2004. View at Google Scholar · View at Scopus
  16. D. C. Cobben, P. L. Jager, P. H. Elsinga, B. Maas, A. J. H. Suurmeijer, and H. J. Hoekstra, “3′-18F-fluoro-3′-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?” Journal of Nuclear Medicine, vol. 44, no. 12, pp. 1927–1932, 2003. View at Google Scholar · View at Scopus
  17. B. Smyczek-Gargya, N. Fersis, H. Dittmann et al., “PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 5, pp. 720–724, 2004. View at Google Scholar · View at Scopus
  18. L. M. Kenny, D. M. Vigushin, A. Al-Nahhas et al., “Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods,” Cancer Research, vol. 65, no. 21, pp. 10104–10112, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. N. Gordon, J. T. Fleagle, D. Guthrie, D. E. Parkin, M. E. Gore, and A. J. Lacave, “Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan,” Journal of Clinical Oncology, vol. 19, no. 14, pp. 3312–3322, 2001. View at Google Scholar · View at Scopus
  20. Y. J. Chang, C. H. Chang, C. Y. Yu et al., “Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model,” Nuclear Medicine and Biology, vol. 37, no. 1, pp. 95–104, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. G. D. Luker, V. Sharma, C. M. Pica et al., “Noninvasive imaging of protein-protein interactions in living animals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 10, pp. 6961–6966, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. H. Chang, K. H. Fan, T. J. Chen et al., “Dynamic evaluation of 18F-FDG upatke by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model,” Journal of the Formosan Medical Association, vol. 103, no. 11, pp. 876–881, 2004. View at Google Scholar
  23. D. L. Francis, D. Visvikis, D. C. Costa et al., “Potential impact of [18F]3′-deoxy-3′ -fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 7, pp. 988–994, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K. Ott, K. Herrmann, F. Lordick et al., “Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study,” Clinical Cancer Research, vol. 14, no. 7, pp. 2012–2018, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. Y. J. Yang, J. S. Ryu, S. Y. Kim et al., “Use of 3′-deoxy-3′-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 4, pp. 412–419, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. C. Murayama, N. Harada, T. Kakiuchi et al., “Evaluation of D-18F-FMT, 18F-FDG, L- 11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice,” Journal of Nuclear Medicine, vol. 50, no. 2, pp. 290–295, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. Dimitrakopoulou-Strauss and L. G. Strauss, “The role of 18F-FLT in cancer imaging: does it really reflect proliferation?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 3, pp. 523–526, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. R. Kameyama, Y. Yamamoto, K. Izuishi et al., “Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 3, pp. 382–388, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. Y. Yamamotoa, R. Kameyamaa, K. Izuishib et al., “Detection of colorectal cancer using 18F-FLT PET: comparison with 18F-FDG PET,” Nuclear Medicine Communications, vol. 30, no. 11, pp. 841–845, 2009. View at Publisher · View at Google Scholar · View at PubMed